Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study
Background Since the release of the first global hepatitis elimination targets in 2016, and until
the COVID-19 pandemic started in early 2020, many countries and territories were making …
the COVID-19 pandemic started in early 2020, many countries and territories were making …
[HTML][HTML] Hepatitis D double reflex testing of all hepatitis B carriers in low-HBV-and high-HBV/HDV-prevalence countries
Hepatitis D virus (HDV) infection occurs as a coinfection with hepatitis B and increases the
risk of hepatocellular carcinoma, decompensated cirrhosis, and mortality compared to …
risk of hepatocellular carcinoma, decompensated cirrhosis, and mortality compared to …
[HTML][HTML] Greater prevalence of comorbidities with increasing age: Cross-sectional analysis of chronic hepatitis B patients in Saudi Arabia
…, MH Ismail, WK Alhamoudi, AM Alalwan… - Saudi Journal of …, 2019 - journals.lww.com
Results: A total of 765 CHB patients were identified in 2010 (n= 274), 2012 (n= 256), and
2015 (n= 235). Median age was significantly higher in 2015 (47 years) compared to 2010 and …
2015 (n= 235). Median age was significantly higher in 2015 (47 years) compared to 2010 and …
Real life efficacy of ledipasvir/sofosbuvir in hepatitis C genotype 4–infected patients with advanced liver fibrosis and decompensated cirrhosis
…, MS Aljawad, AS Alghamdi, AA Aljumah, AM Alalwan… - Journal of Infection, 2018 - Elsevier
Limited clinical trial data has shown high efficacy of co-formulated ledipasvir/sofosbuvir (LDV/SOF)
in the treatment of hepatitis C virus (HCV) genotype (GT)-4 infected cirrhotic patients. …
in the treatment of hepatitis C virus (HCV) genotype (GT)-4 infected cirrhotic patients. …
[HTML][HTML] Efficacy and safety of treatment of hepatitis C virus infection in renal transplant recipients
…, AI Al Flaiw, IH Al Traif, AM Al Alwan… - World journal of …, 2012 - ncbi.nlm.nih.gov
AIM: To assess the efficacy and safety of combined pegylated interferon and ribavirin therapy
in hepatitis C virus (HCV) infection in renal transplant recipients. METHODS: This is a …
in hepatitis C virus (HCV) infection in renal transplant recipients. METHODS: This is a …
[HTML][HTML] Clinical practice guidelines for liver transplantation in Saudi Arabia
…, WA O'Hali, NM Almasri, AA Alalwan… - Saudi Medical …, 2021 - ncbi.nlm.nih.gov
Clinical Practice Guidelines for Liver Transplantation in Saudi Arabia - PMC Back to Top Skip
to main content NIH NLM Logo Access keys NCBI Homepage MyNCBI Homepage Main …
to main content NIH NLM Logo Access keys NCBI Homepage MyNCBI Homepage Main …
Global prevalence, cascade of care, and prophylaxis coverage of hepatitis B in 2022: a modelling study
…, I Aho, U Akarca, N Al Masri, A Alalwan… - The Lancet …, 2023 - thelancet.com
Background The 2016 World Health Assembly endorsed the elimination of hepatitis B virus (HBV)
infection as a public health threat by 2030; existing therapies and prophylaxis …
infection as a public health threat by 2030; existing therapies and prophylaxis …
[HTML][HTML] Effectiveness of generic sofosbuvir in the treatment of chronic hepatitis C virus infection in Saudi patients
…, KM AlThiab, AA AlOun, AM AlAlwan… - Saudi Medical …, 2023 - ncbi.nlm.nih.gov
Objectives: To assess the effectiveness of generic sofosbuvir (SOF) and branded daclatasvir
(DCV) for the treatment of chronic hepatitis C virus (HCV) infected patients. Methods: This …
(DCV) for the treatment of chronic hepatitis C virus (HCV) infected patients. Methods: This …
Effect of erythromycin before endoscopy in patients presenting with variceal bleeding: a prospective, randomized, double-blind, placebo-controlled trial
I Altraif, FA Handoo, A Aljumah, A Alalwan… - Gastrointestinal …, 2011 - Elsevier
BACKGROUND:: Blood in the stomach and esophagus in patients with variceal bleeding
often obscures the endoscopic view and makes endoscopic intervention difficult to perform. …
often obscures the endoscopic view and makes endoscopic intervention difficult to perform. …
[HTML][HTML] Clinical presentation, risk factors, and treatment modalities of hepatocellular carcinoma: a single tertiary care center experience
…, F Azzumeea, B Almutairi, A AlAlwan… - … Research and Practice, 2016 - hindawi.com
Objective. To investigate the risk factors, clinical characteristics, treatment modalities, and
outcomes in Saudi patients with HCC and propose points for early detection of the disease. …
outcomes in Saudi patients with HCC and propose points for early detection of the disease. …